Otros idiomas COSMOS Pharmaceutical Corporation

Acciones

3349

JP3298400007

Mercado cerrado - Japan Exchange Otros sitios de cotización 08:00:00 05/07/2024			Varia. Cinco días.	Varia. 1 de enero.
12.785 ^JPY	-2,18 %		-2,03 %	-21,49 %

12/04	El beneficio atribuible de Cosmos Pharmaceutical aumenta un 6,6% en los nueve meses fiscales	MT
12/04	COSMOS Pharmaceutical Corporation proporciona una guía de dividendos para el año fiscal que finaliza el 31 de mayo de 2024	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	12/04
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	12/04
Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores	12/01
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	12/01
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending May 31, 2024, Payable on February 13, 2024; Provides Year Dividend Guidance for fiscal Year Ending May 31, 2024	12/01
Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores	12/10/23
COSMOS Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended August 31, 2023	11/10/23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	11/10/23
Revenez, la semaine n'est pas finie !	08/08/23
AVIS D'ANALYSTES DU JOUR : Saint-Gobain, AXA, Crédit Agricole, Adidas, Demant, Ipsen, Just Eat...	08/08/23
Cosmos Attributable Profit Increases 2.8% in Fiscal Year 2023	11/07/23
COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Year Ended May 31, 2023, Payable on August 3, 2023; Provides Dividend Guidance for the Second Quarter-End and Full Year of Full Year Ending May 31, 2024	10/07/23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	10/07/23
Cosmos Pharma's Attributable Profit Slides 1% in Fiscal Nine Months Amid New Store Openings	11/04/23
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	10/04/23
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal year ending May 31, 2023	10/04/23
AVIS D'ANALYSTES DU JOUR : Airbus, Thales, STMicroelectronics, FDJ, Ubisoft, TF1, Ferrari, Cosmo...	31/01/23
Cosmos Pharma Books Marginal Rise in Fiscal H1 Attributable Profit Amid New Store Openings, Low-cost Strategy	16/01/23
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter of Fiscal 2023; Provides Dividend Guidance for the Full Year of Fiscal Year Ending May 31, 2023	13/01/23
Cosmos Pharmaceutical Corporation Provides Earnings Forecast for the Fiscal Year Ending May 31, 2023	13/01/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas COSMOS Pharmaceutical Corporation

Acciones

3349

JP3298400007

Otros idiomas

Filtros